Samsung BioLogics signed CDO(Contract Development Organization) contract with GI Innovation |
May 03, 2019 | May 2019 Bond Updates |
SEOUL, South Korea, May 3, 2019 /PRNewswire/ -- Samsung BioLogics (CEO: Tae Han Kim) and GI Innovation (CEO: Soo Yeon Nam) signed a Contract Development Organization (CDO) contract for immunochemotherapy at Samsung BioLogics headquarters on Thursday. GI Innovation signed this second... |
View more at: https://www.prnewswire.com:443/news-releases/samsung-biologics-signed-cdocontract-development-organization-contract-with-gi-innovation-300843416.html |
Related News |
|